新型SCCmec类型的甲素耐药黄金葡萄球菌携带CRISPR-cas系统,从中国的一头猪中分离出来
Qianhong Liu1, Ruyun Zhuo1, Wuxia He1
1College of Animal Science, Xichang University, Xichang, China.
Microbial pathogenesis
|August 2, 2025
概括
在牲畜相关的MRSA菌株中,一种新的CRISPR-Cas系统提供了对菌体的部分保护. 这一发现揭示了MRSA如何适应,在水平基因转移的同时保持防御机制.
科学领域:
- 微生物学 微生物学
- 基因组学就是基因组学.
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 甲素耐药黄金葡萄球菌 (MRSA) 是一个全球性的健康问题,在各种环境中发现.
- 畜牧业相关的MRSA (LA-MRSA) 由于其在动物种群中循环,造成了独特的挑战.
研究的目的:
- 鉴定一种新型葡萄球菌带染色体mec (SCCmec) 类型,该类型在来自猪的LA-MRSA中发现.
- 为了研究这个新的SCCmec元素中集成的CRISPR-Cas系统的功能.
主要方法:
- 基因组测序和MRSA分离物的结构分析.
- 功能性测试以评估CRISPR-Cas系统对菌体和等离子体挑战的活性.
- 对cas10基因表达的定量分析.
主要成果:
- 在中国的一种LA-MRSA菌株 (LS45) 中发现了一种新型SCCmec类型XIII (9A).
- 这种SCCmec类型包含一个功能性的CRISPR-Cas系统 (cas10-csm2-csm3-csm4-csm5-csm6).
- 克里斯普尔-卡斯系统在低感染次数的情况下提供了对菌体感染的部分免疫力,但不是对等离子体.
结论:
- 在LA-MRSA中,新型SCCmec元素和功能CRISPR-Cas系统的共同位置突出了细菌适应策略.
- 这一发现为MRSA的基因组可塑性及其在经历横向基因转移时获得防御系统的能力提供了新的见解.
关键词:
抗微生物耐药性 抗微生物耐药性这就是CRISPR-Cas.这就是LA-MRSA.这就是SCCmec.ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9 ST9更多相关视频
07:26Intracranial Subarachnoidal Route of Infection for Investigating Roles of Streptococcus suis Biofilms in Meningitis in a Mouse Infection Model
Published on: July 1, 2018
7.4K
05:51Construction of CRISPR Plasmids and Detection of Knockout Efficiency in Mammalian Cells through a Dual Luciferase Reporter System
Published on: December 5, 2020
6.4K
相关概念视频
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR and crRNAs
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced Short...
CRISPR/Cas9 Genome Editing
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
